Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Providence Health & Services
With
Oregon Health and Science University
The quality of the immune environment in colorectal cancer biopsy samples correlates with disease-free survival and overall survival more so than current staging conventions. This study will use a scoring system called 'immunoscore' to characterize the immune enviroment. Researchers hypothesize that the immunoscore will correlate with outcomes of colorectal patients treated with neoadjuvant chemoradiation.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with a diagnosis of a rectal mass suspicious for or known to be an adenocarcinoma of the rectum.
Age \> 18
Ability to give informed consent and comply with the protocol. Patients with a history of psychiatric illness must be judged able to understand fully the investigational nature of the study and the risks associated with the therapy.
You may not be if
History of other malignancy in the past 2 years except carcinoma in situ of the cervix or bladder, or non-melanomatous skin cancer
Other medical or psychiatric conditions that in the opinion of the Principal Investigator would preclude safe participation in protocol.
